Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization
Authors:
- Donald B. MaierDMDonald B. Maier
- John C. NulsenJNJohn C. Nulsen
- Claudio A. BenadivaCBClaudio A. Benadiva
- 1 October 2004
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 82 (4) , 841-846
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Endocrine Profiles after Triggering of Final Oocyte Maturation with GnRH Agonist after Cotreatment with the GnRH Antagonist Ganirelix during Ovarian Hyperstimulation forin VitroFertilizationThe Journal of Clinical Endocrinology & Metabolism, 2002
- Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndromeHuman Reproduction, 2000
- Severe OHSS: How many cases are preventable?Human Reproduction, 2000
- Albumin in the prevention of severe OHSSHuman Reproduction, 1999
- Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safetyHuman Reproduction, 1999
- Diagnosis, prevention and management of ovarian hyperstimulation syndromeBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- The luteinizing hormone surge—the final stage in ovulation induction: modern aspects of ovulation triggeringFertility and Sterility, 1995
- Luteinizing Hormone Requirements for Ovulation in the RatBiology of Reproduction, 1992
- Severe ovarian hyperstimulation syndrome: role of peripheral vasodilationFertility and Sterility, 1991
- Risk factors and prognostic variables in the ovarian hyperstimulation syndromeAmerican Journal of Obstetrics and Gynecology, 1988